Overall (n=26) | Group 1 (n=12) | Group 2 (n=14) | P value | |
Age, mean (SD), years | 46.5 (12.7) | 48.3 (12.3) | 45.0 (13.2) | 0.571 |
Female, % | 23 | 17 | 29 | 0.652 |
Time since amputation, mean (SD), years | 7.0 (6.6) | 6.4 (4.6) | 7.5 (8.1) | 0.877 |
Time since onset of RLP, mean (SD), years | 7.1 (6.9) | 5.9 (4.4) | 8.2 (8.6) | 0.735 |
Time since onset of PLP, mean (SD), years | 7.0 (6.8) | 6.3 (4.9) | 7.5 (8.1) | 0.978 |
Level of amputation | 0.021 | |||
Above knee, n (%) | 15 (58) | 10 (83) | 5 (36) | |
Below knee, n (%) | 11 (42) | 2 (17) | 9 (64) | |
Treatment history (% currently in use, % previously in use) | ||||
Opioid medication | 42, 50 | 42, 50 | 43, 50 | >0.999 |
Non-opioid medications | 65, 27 | 67, 25 | 64, 29 | >0.999 |
Surface stimulation | 0, 31 | 0, 33 | 0, 29 | >0.999 |
Spinal cord stimulation | 0, 0 | 0, 0 | 0, 0 | – |
Physical therapy | 4, 81 | 0, 83 | 7, 79 | >0.999 |
Acupuncture | 0, 8 | 0, 8 | 0, 7 | >0.999 |
Steroid injection | 0, 15 | 0, 8 | 0, 21 | 0.598 |
Botulinum toxin injection | 0, 0 | 0, 0 | 0, 0 | – |
Nerve block | 0, 19 | 0, 17 | 0, 21 | >0.999 |
Other | 4, 8 | 0, 17 | 7, 0 | 0.337 |
PLP, phantom limb pain; RLP, residual limb pain.